Literature DB >> 16831076

Early clinical detection of ovarian cancer: a review of the evidence.

Lloyd H Smith1.   

Abstract

Subjective and objective evidence suggest that a third to half of patients developing ovarian cancer report symptoms at 3 or more months prior to diagnosis. Early ovarian cancer-associated symptoms constitute a constellation of mostly nongynecological complaints, suggesting a visceral disturbance, which do not point immediately to a pelvic origin. Abdominal bloating and pain predominate with recent onset and multiple symptomatic episodes. Gastrointestinal and urinary symptoms and fatigue/malaise may be part of the symptom complex. Women aged 50 years and older with this constellation of symptoms should have medical evaluation and, if symptoms are unexplained or persist, should undergo pelvic imaging (e.g., transvaginal ultrasound) and serum CA125.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16831076     DOI: 10.1586/14737140.6.7.1045

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  3 in total

1.  Role of sex hormones in modulating breast and ovarian cancer associated pain.

Authors:  Melissa C McHann; Henry L Blanton; Josée Guindon
Journal:  Mol Cell Endocrinol       Date:  2021-05-24       Impact factor: 4.369

Review 2.  Diagnostic value of osteopontin in ovarian cancer: a meta-analysis and systematic review.

Authors:  Zhi-De Hu; Ting-Ting Wei; Min Yang; Ning Ma; Qing-Qin Tang; Bao-Dong Qin; Hai-Tao Fu; Ren-Qian Zhong
Journal:  PLoS One       Date:  2015-05-07       Impact factor: 3.240

3.  Cellular fibroma of the ovary with multiloculated macroscopic characteristics: case report.

Authors:  Sheila Jorge Adad; Valeria Lima Laterza; Carlos David Teixeira Dos Santos; Antonio Alexandre Lisboa Ladeia; Joao Carlos Saldanha; Cleber Sergio da Silva; Luis Ronan Marquez Ferreira E Souza; Eddie Fernando Candido Murta
Journal:  Case Rep Med       Date:  2012-04-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.